Stockpolly
Search
SNSE · NASDAQ · Biotechnology

Sensei Biotherapeutics (SNSE)

Clinical-stage biotech developing PIKTOR and solnerstotug for solid tumor cancers.

$13.85
At close−3.97 (−22.28%)
Watchlist

In millions of USD, except per-share figures

In millionsQ3 FY23Sep 2023Q4 FY23Dec 2023Q1 FY24Mar 2024Q2 FY24Jun 2024Q3 FY24Sep 2024Q4 FY24Dec 2024Q1 FY25Mar 2025Q2 FY25Jun 2025Q3 FY25Sep 2025Q4 FY25Dec 2025Q1 FY26Mar 2026Q2 FY26Jun 2026
Revenue00000000−5000
Cost of revenue00000000−501330
Gross profit0000000000−1330
78988775553818
Research & development4455544332189
3443334323209
Selling & marketing000000000000
General & administrative0040004323209
Operating income−8−8−9−8−8−7−7−5−5−5−171−18
111110000002
Interest income111111000002
Interest expense000000000000
Other non-operating income−1−1−1−1−1000000−2
Income before tax−7−7−8−7−7−8−7−5−5−5−170−16
Net income from continuing operations−7−7−8−7−7−8−7−5−5−5−170−16
Net income−7−7−8−7−7−8−7−5−5−5−170−16
EPS, basic−$0.28−$0.30−$0.32−$0.28−$0.29−$0.31−$0.27−$3.91−$3.62−$8.92−$131.45−$2.84
EPS, diluted−$0.28−$0.30−$0.32−$0.28−$0.29−$0.31−$0.27−$3.91−$3.62−$8.92−$131.45−$2.84
Weighted average shares, basic2625252525252511116
Weighted average shares, diluted2625252525252511116
EBITDA−7−7−8−7−7−8−7−5−5−5−170−16
Depreciation & amortization000000000000
EBIT−7−7−8−7−7−8−7−5−5−5−170−16